RxDoctor Payments Data

Jitinder Singh, DO

Family Medicine · New Lenox, ILNPI 1194812602

Payments from drug & device makers

$424in general payments, 2019–2025

Across 22 payments — averaging $19.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$84
  • AbbVie$74
  • AstraZeneca$52
  • Abbott$49
  • Medtronic$25
  • Kowa Pharmaceuticals America, Inc.$24
  • plus $116 from 7 others

What the payments were for

  • Food & beverage$41297%
  • Education$113%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$424 in reported general payments places this provider in the 60th percentile of 4,116 family medicine providers in Illinois.

See all family medicine providers in Illinois

Medicare billing

Part B allowed, 2024
$249,391
Medicare patients
737
Services billed
2,990

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban76$118,657
JanuviaSitagliptin Phosphate76$99,095
MounjaroTirzepatide87$98,247
FarxigaDapagliflozin Propanediol64$79,193
JardianceEmpagliflozin52$69,622
TrulicityDulaglutide45$60,280
OzempicSemaglutide45$45,481
XareltoRivaroxaban17$26,534
Trelegy ElliptaFluticasone/Umeclidin/Vilanter15$23,731
Spiriva RespimatTiotropium Bromide15$12,924
Breztri AerosphereBudesonide/Glycopyr/Formoterol15$10,871
Atorvastatin Calcium1,067$10,792
Levothyroxine Sodium632$8,949
Fiasp FlextouchInsulin Aspart (Niacinamide)11$8,785
Lantus SolostarInsulin Glargine,hum.Rec.Anlog42$7,608

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$14$118,65776 claims
AstraZenecaFarxiga, Breztri Aerosphere, Symbicort$52$93,88194 claims
Novo NordiskOzempic$84$45,48145 claims
AbbVieSynthroid$74$4,72858 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 4,116 family medicine providers in Illinois.

Other family medicine in New Lenox

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →